Skip to main content
. 2021 Apr 28;28(10):3517–3529. doi: 10.1111/ene.14860

FIGURE 3.

FIGURE 3

Pooled prevalence of acute inflammatory demyelinating polyneuropathy subtype amongst COVID‐19‐associated Guillain−Barré syndrome spectrum cases, stratified by study design (a) and probability of acute inflammatory demyelinating polyneuropathy subtype in COVID‐19‐associated Guillain−Barré syndrome spectrum cases compared to contemporary or historical controls (b) [Colour figure can be viewed at wileyonlinelibrary.com]